Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
The highly transmissible Omicron variant of SARS-CoV-2 caused many infections in Newfoundland and Labrador (NL), and the fraction of infections that were unreported varied as PCR testing capacity was exceeded and eligibility rules changed. Due to these inconsistencies in the testing rate, we developed a mechanistic model that was calibrated to seroprevalence data (Dec 2021–May 2022) to estimate underreporting and understand the impact of non-pharmaceutical interventions on transmission. Our model considers the epidemiology of SARS-CoV-2 spread, natural and vaccine-derived immunity, and the booster dose vaccination campaign that was ongoing in NL during the study. We found that during the early spread of the Omicron variant, when the eligibility for tests that were reported in the provincial counts was less restrictive, fewer than 3 infections were unreported per reported case. After March 17, 2022, when test eligibility was more restrictive, the underreporting rate increased steadily, with an average of 21 infections unreported infections per reported case. We found that Omicron transmission was lower when schools were closed (mean reproduction number, ℛ 0 = 1.44, 95% CI: 1.41–1.47), higher when open (mean ℛ 0 = 2.03, 95% CI: 1.60–2.46), and of the alert levels, ALS-4 reduced transmission the most (mean ℛ 0 = 1.52, 95% CI: 1.35–1.69). When underreporting rates vary, the impact of non-pharmaceutical interventions, such as alert level systems and school closures, cannot be determined from reported cases. Our findings highlight the value of combining seroprevalence data with modelling to determine the impact of NPIs during pandemics when surveillance systems are constrained. ALS-4 reduced spread the most
Author summary
Reported COVID-19 cases often underestimate the number of infections, especially when testing capacity is exceeded or eligibility rules change. This occurred in Newfoundland and Labrador (NL), Canada, during the spread of the Omicron variant, when testing rates were uneven and many infections were unreported. Our analysis showed that underreporting increased substantially when eligibility for tests that could be reported in the official counts was restricted to high-risk individuals and people who work with high-risk individuals. Given this eligibility change, the underreporting ratio increased from 3 to an average of 21 unreported infections per reported case. We used an epidemiological model to account for the many factors, such as asymptomatic infections and vaccination status, that are known to affect infection spread. We found that transmission was lower when schools were closed, higher when schools were open, and of the alert levels, ALS-4 reduced spread the most. These results highlight that reported cases alone can produce inaccurate results when testing systems are constrained and the rate of testing is variable. Using our approach of combining serological data with modelling enabled us to evaluate the impact of public health measures. These results support knowledge mobilization to explain to the public why particular public health measures are being implemented during an emergency.
